RxDoctor Payments Data

Jason Lopez, MD

Psychiatry · South Miami, FLNPI 1659802916

Payments from drug & device makers

$5,983in general payments, 2019–2025

Across 87 payments — averaging $68.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$4K
  • AbbVie$509
  • Teva Pharmaceuticals USA, Inc.$413
  • Axsome Therapeutics, Inc.$250
  • Neurocrine Biosciences, Inc.$221
  • Otsuka America Pharmaceutical, Inc.$206
  • plus $649 from 10 others

What the payments were for

  • Food & beverage$2,15236%
  • Education$1112%
  • Other$3,72062%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,983 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$502,678
Medicare patients
101
Services billed
2,456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl49$68,512
LybalviOlanzapine/Samidorphan Malate14$21,329
Olanzapine278$14,544
TrintellixVortioxetine Hydrobromide17$14,158
Mirtazapine1,094$12,540
Lurasidone Hcl38$11,208
Aripiprazole177$10,383
Escitalopram Oxalate2,095$10,066
Quetiapine Fumarate1,214$9,630
Trazodone Hcl822$5,320
Duloxetine Hcl209$4,347
Divalproex Sodium78$4,264
Venlafaxine Hcl ErVenlafaxine Hcl92$3,986
Clonazepam647$3,641
Bupropion XlBupropion Hcl348$3,177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$509$68,51249 claims
Alkermes, Inc.Lybalvi$133$21,32914 claims
Almatica Pharma LLCSertraline Hcl$28$1,815542 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in South Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →